Status:
UNKNOWN
Efficacy of Expressive Writing in Mothers of Preterm Infants
Lead Sponsor:
Universidad Industrial de Santander
Conditions:
Premature Infant
Mothers
Eligibility:
FEMALE
14-49 years
Phase:
NA
Brief Summary
Premature birth can lead the mother to lose control of herself, and be a contributor to the psychological stress experienced due to the sudden breakdown of the interaction with her infant because of h...
Detailed Description
Background: The literature has shown the application of expressive writing therapy after traumatic events, and the measurement of its impact on people´s health through the application of quantitative ...
Eligibility Criteria
Inclusion
- Mothers with:
- Age of 14 or more years old
- Preterm newborns with a gestational age of less than 34 weeks
- Preterm newborns who are hospitalized in the NICU of the third level Hospital of Santander
- Preterm newborns alive at the time of assignment to the control group or intervention group
- The time of hospitalization of the newborn must be at least one week at the hospital.
- Nursing Diagnosis Readiness for enhanced parenting (00164)
Exclusion
- Limitations as hearing, motor and / or mental disability measured through the minimenta test.
- Active consumption of psychoactive substances
- Mothers who can not read or write,
- Mothers of newborns with a confirmed diagnosis of severe diseases like congenital malformations.
Key Trial Info
Start Date :
October 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 30 2020
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT03423914
Start Date
October 1 2017
End Date
November 30 2020
Last Update
February 21 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Universitario de Santander
Bucaramanga, International, Colombia, 68